PRECLINICAL AND CLINICAL ASPECTS OF THE DEVELOPMENT OF BIOMEDICAL CELL PRODUCTS
The article reviews literature data on development and clinical use of biomedical cell products (BCPs) — a new class of medicines which could be approved for distribution and use only after their specific activity and safety have been thoroughly examined at the stage of experimental research. The ar...
Main Authors: | A. V. Tikhomirova, D. V. Goryachev, V. A. Merkulov, I. V. Lysikova, A. I. Gubenko, A. I. Zebrev, А. P. Solovieva, D. P. Romodanovsky, E. V. Melnikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
NEICON ISP LLC
2018-03-01
|
Series: | Ведомости Научного центра экспертизы средств медицинского применения |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/153 |
Similar Items
-
Design of preclinical studies of biomedical cell products: characteristics, key principles and requirements
by: E. V. Melnikova, et al.
Published: (2018-02-01) -
Justification of Methodological Approaches to Identification Testing of Biomedical Cell Products
by: E. V. Melnikova, et al.
Published: (2019-03-01) -
Biomedical Cell Products or High-Tech Drugs?
by: V. A. Merkulov, et al.
Published: (2019-06-01) -
Use of Cytogenetic Analysis Methods for Assessing the Quality of Cell Lines in Biomedical Cell Products
by: O. A. Rachinskaya, et al.
Published: (2018-03-01) -
Quality Standards of Preclinical Pharmacological Studies
by: G. N. Engalycheva, et al.
Published: (2019-12-01)